The objective of this study was to investigate the relationship between recurrent nightmare and indefinite complaints and to determine the explanatory variables of indefinite complaints related to nightmares in hemodialysis (HD) patients. Sleep quality and dream anxiety in nightmare were assessed with the Athens Insomnia Scale and Van Dream Anxiety Scale. Using a visual analog scale and the Beck Depression Inventory, we assessed the presence of indefinite complaints and levels of depressive symptoms, respectively. Moreover, logistic regression analysis was performed to determine the risk factors of dream anxiety in recurrent nightmare. The presence of feelings of malaise was an independent risk factor of recurrent nightmare (OR, 1.360; p = 0.0083). Adjustment for the presence of feelings of malaise could help to reduce the frequency of nightmares or sleep disorders in patients undergoing HD treatment. Our findings will be useful when considering adjustment of the HD dose.
INTRODUCTION
Nightmares that occur repeatedly and frequently are considered a sleep disorder. Frequent occurrence of nightmares becomes a major distress of the everyday life, or bedtime anxiety about having another nightmare. It may be referred to as repeated nightmares (recurrent nightmares) or dream anxiety disorder, which can be defined as a series of nightmares with a recurring theme. Although the reasons why nightmares occur are unclear, they may be linked to mental health disorders, emotional problems, depressive symptoms, severe stress, post-traumatic stress disorder (PTSD), drugs, or traumatic events [1] . Previous studies have reported that approximately 2-7% of adults experience nightmare that can be classified as a sleep disorder. Sleep disorders are a common and frequent problem among patients undergoing maintenance hemodialysis (HD) [2, 3] . The prevalence of sleep disorders in HD patients is higher than in the general population, and 70-80% of dialysis patients suffer from sleep abnormalities or disturbances [4] [5] [6] .
Sleep disorders in HD patients are affected by factors such as restless legs syndrome, uremic pruritus, and feelings of malaise. These symptoms are assessed as indefinite complaints in some cases because their causes are not clear. However, sleep disorders are considered to be responsible not only for a decline in the quality of life (QOL) of HD patients but also for an increased mortality risk. Although indefinite complaints are commonly encountered in HD patients and often presumed to be associated with nightmares and sleep disorders, most studies have not explored them as a possible confounding factor. Despite an increasing concern regarding the relationship between sleep disorders and indefinite complaints, HD patients with nightmares are rarely evaluated clinically. We hypothesized that recurrent nightmares may be associated with a high comorbidity of indefinite complaints and anxiety disorder, particularly in HD patients. To our knowledge, there are few reports on indefinite complaints and related factors influencing recurrent nightmares. In this study, we investigated the relationship between dream anxiety in recurrent nightmare and indefinite complaints in HD patients based on clinical practice.
METHODS

Study population
One hundred and fifty-two patients (mean age: 65.9 ± 11.4 years; 50% females; dialysis vintage: 14.2 ± 8.8 years) undergoing maintenance HD three times per week for more than 1 year were included in this cross-sectional study. Patients who declined to be enrolled in the study and those who could not complete the questionnaire themselves were excluded. Patients with low cognitive function were also excluded from the study. As a result, 130 patients were enrolled as study participants. The Ethics Committee for 
Biochemical measurements
We extracted the following clinical characteristics from patients' medical records: sex, age, presence of underlying diabetes mellitus (DM), dialysis vintage, body mass index (BMI), mode of dialysis therapy (HD or Online Hemodiafiltration; HDF), HD time, blood flow rate during HD, and HD dose (Kt/V ure ). Dry weight (DW) was determined based on clinical grounds, and reflected the lowest weight the patient could tolerate without intradialytic symptoms and hypotension in the absence of overt fluid overload. DW was updated according to changes in physicians' orders throughout the observation. BMI was calculated as patients' DW divided by the square of their height, expressed in units of kg/m 2 . All study data were obtained via medical chart reviews. Blood samples (4 mL) were obtained just prior to initiation of HD at the start of a regular HD session on the first day of the week. Laboratory data, including hemoglobin levels, serum ferritin levels, blood urea nitrogen (BUN), serum albumin levels, creatinine (Cr), and C-reactive protein (CRP), were obtained. Serum ferritin levels, transferrin saturation (TSAT), and CRP were measured using the latex agglutination turbidimetry method. TSAT was calculated as serum iron levels divided by total iron binding capacity. The geriatric nutritional risk index (GNRI) was calculated as follows: GNRI = [14.89 × serum albumin levels (g/dL) + 41.7 × (body weight/ideal body weight)] [7] . Ideal body weight was calculated using the patients' height and a BMI of 22 kg/m 2 [8, 9] . HD dose (Kt/V ure ) was calculated at the beginning of the week. Kt/V ure was determined according to a single-pool urea kinetics model [10] .
Assessment of Insomnia
The Athens Insomnia Scale (AIS) was used to assess insomnia symptoms. The AIS consists of an 8-item standardized self-assessment psychometric instrument designed for quantifying sleep difficulty. The AIS assesses difficulty with sleep induction, awakening during the night, early morning awakening, total sleep time, and overall quality of sleep; as well as next-day consequences of insomnia, including problems with sense of well-being, functioning, and sleepiness during the day [11] . Each item of the AIS is rated from 0 to 3, and patients with a score of 6 or higher are diagnosed with insomnia [12] .
Assessment of dream anxiety
The Van Dream Anxiety Scale (VDAS) was used to assess dream anxiety. There are 17 self-rated questions in the scale (Cronbachs α, 0.87) [13] . Four questions, questions 7-10, are about for clinical information. Twelve questions are concerned with nightmare frequency, difficulty falling asleep after a nightmare, fear of sleeping because of anticipated nightmares, troubled sleeping, dream recall frequency, sleepiness, morning anxiety, occupational distress, familial distress, social distress, psychological disturbances, and memory/concentration problems. These 12 questions are weighted equally on a scale from 0 to 4 (0 = never; 1 = rarely; 2 = sometimes; 3 = usually; and 4 = often). Question 5 is related to autonomic hyperactivity and consists of 12 symptoms (shortness of breath, dizziness, exhaustion, palpitation, sweating, shivering, nausea, stomach ache, chest tightness, dry mouth, fear of death, and sore throat). Each of the 12 symptoms is weighted on a scale from 0 to 4. If the total score is between 0 and 10, the sum score of the question is 0, between 11 and 20 = 1, between 21 and 30 = 2, between 31 and 40 = 3, and between 40 and 48 = 4. Subsequently, the thirteen scores are summed to yield a global VDAS score, which ranges from 0 to 52 [13] .
Assessment of depressive symptoms
The Beck Depression Inventory Second Edition (BDI-II, Japanese version) was used to quantify patients' depression levels [14] . The BDI-II is the most widely used instrument for the self-assessment of depression among patients undergoing dialysis [15, 16] . There are 21 items on the self-administered questionnaire that assess both the presence and severity of depression, with the possible responses scored from 0 to 3 and total scores ranging from 0 to 63 [17] . A higher BDI-II score indicates a greater level of depression. In the present study, we defined patients with BDI-II scores ≥ 14 as having depressive symptoms [18] .
Assessment of indefinite complaints
A visual analog scale (VAS) was used to assess the following indefinite complaints related to hemodialysis therapy: prevalence of uncomfortable and unpleasant sensations in the legs caused by restless legs syndrome (Q1), prevalence of uremic pruritus (itching skin) (Q2), prevalence of feelings of malaise (Q3), prevalence of unwell feelings during an HD session caused by intradialytic hypotension (IDH) (Q4), and presence of anorexia (Q5). The VAS consisted of a horizontal line ranging from 0 cm (no symptoms) to 10 cm (worst imaginable symptoms). 
Statistical analysis
All data were expressed as medians and interquartile ranges (IQR) or mean ± standard deviation (SD). The patients were divided into 2 groups, nightmare sufferers and nightmare non-sufferers (control group), based on their self-declarations on the presence of dream anxiety in nightmare. There are large individual differences in the suffering caused by nightmares. There are both those who are severely afflicted and those who do not suffer greatly. In this study, we determined the presence or absence of nightmares through self-reports by patients who were suffering physically or mentally, though there were differences in the extent.
The clinical characteristics of the two groups were compared using a Mann-Whitney U test for age, BMI, dialysis vintage, HD time, blood flow rate during HD, VDAS scores, BDI-II scores, AIS scores, laboratory variables, and VAS. Fisher's exact probability tests were used to compare the proportions of sex and the presence of underlying DM between groups.
Logistic regression analysis was performed to select determinants between patients grouped by the presence or absence of dream anxiety in nightmare (the dependent variable). The presence or absence of depressive symptoms according to the BDI-II score, VAS score for uncomfortable and unpleasant sensations in the legs caused by restless legs syndrome, VAS score for uremic pruritus (itching skin), VAS score for feelings of malaise, VAS score for unwell feelings during HD sessions caused by IDH, and VAS score for anorexia were included in the model. Data are presented as odds ratios (ORs) with 95% confidence intervals (CIs). All statistical analyses were performed using EZR (Saitama Medical Center, Jichi Medical University, Saitama, Japan), which is a graphical user interface for R (The R Foundation for Statistical Computing, Vienna, Austria) [19] . Table 1 shows the patients' clinical characteristics, categorized by the presence or absence of dream anxiety Table 1 : Clinical and biochemical data of patients at the start of the study in nightmare. Overall, 22 patients (17%) suffered from dream anxiety in nightmare. There were no statistically significant differences between the nightmare sufferers and the control group with respect to clinical and biochemical data (p > 0.05). Table 2 shows the comparison of AIS, VDAS, and VAS scores for indefinite complaints. The median (IQR) value of the AIS score was 7.5 (9.0-6.3) in the nightmare sufferers group and 3.0 (6.0-41.0) in the control group. The AIS score in the nightmare sufferers group was significantly higher than in the control group (p < 0.0001).
RESULTS
Demographic characteristics
Athens Insomnia Scale
Assessment of dream anxiety
The nightmare sufferers group had significantly higher VDAS scores for nightmare frequency (Q1), difficulty Table 2 : Differences in AIS, BDI-II, VDAS, and VAS scores between the nightmare sufferers and control groups falling asleep after a nightmare (Q2), fear of sleeping because of nightmare (Q3), trouble sleeping (Q4), dream recall frequency (Q6), sleepiness (Q11), morning anxiety (Q12), occupational distress (Q13), familial distress (Q14), social distress (Q15), psychological disturbance (Q16), and memory/concentration problems (Q17) than the control group (all p < 0.0001). In question 5, which is related to autonomic hyperactivity, the nightmare sufferers group had significantly higher scores for shortness of breath (Q5-a), dizziness (Q5-b), exhaustion (Q5-c), palpitation (Q5-d), sweating (Q5-e), dry mouth (Q5-j), and fear of death (Q5-k) than the control group (all p < 0.05). There were no significant differences in the scores for the autonomic hyperactivity components, including shivering (Q5-f), nausea (Q5-g), stomach ache (Q5-h), chest tightness (Q5-i), and sore throat (Q5-l) in questions 7 through 10 (all p > 0.05).
Assessment of depressive symptoms
Comparison of the nightmare sufferers and control group showed that the median (IQR) values of the BDI-II score were 16.0 (22.0-9.0) in the nightmare sufferers and 7.5 (14.5-4.0) in the control group. The BDI-II score in the nightmare sufferers was significantly higher than in the control group (p < 0.0001).
Assessment of indefinite complaints
In the VAS for indefinite complaints, comparison of the nightmare sufferers and control group showed that the scores for uncomfortable and unpleasant sensations in the legs caused by restless legs syndrome (Q1), uremic pruritus (itching skin) (Q2), feelings of malaise (Q3), unwell feelings during an HD session caused by IDH (Q4), and anorexia (Q5) were found to be significantly higher among nightmare sufferers than the control group (p < 0.0001, p = 0.0009, p = 0.0002, p = 0.0007, p = 0.0028, respectively). Table 3 shows the results of univariate logistic regression analysis. Relative to the control group, the nightmare sufferers had increased ORs for the presence of feelings of malaise (OR, 1.360; 95% CI: 1.080-1.719; p = 0.0083). No significant differences were found between the nightmare sufferers and control group for other indefinite complaint variable outcomes or depressive symptoms.
Logistic regression analysis
DISCUSSION
To identify the risk factors for dream anxiety in nightmare among HD patients, we focused on assessing the factors responsible for dream anxiety in nightmare, including clinical, demographic, and laboratory variables that have been previously suggested to be associated with the condition. In our study, based on patient's selfdeclarations of dream anxiety in nightmare, the AIS, BDI-II, VDAS, and VAS for indefinite complaints were used to assess the state of symptoms and causes related to nightmare. The prevalence of suffering from dream anxiety in nightmare was 17% among our patients. In this study, the primary findings were that the presence of feelings of malaise was an independent risk factor for nightmare. That is, the ORs for feelings of malaise in patients suffering from dream anxiety in nightmare were statistically significant.
Previous studies have concluded that 42-88% of HD patients had sleep problems or disorders such as insomnia [20, 22] . In our study, the prevalence of insomnia symptoms according to the AIS scores in nightmare sufferers and the control group was 82% and 25%, respectively. The prevalence of depressive symptoms in the nightmare sufferers and the control group was 45% and 23%, respectively. We observed that patients with recurrent nightmares had significantly higher insomnia symptoms and depressive symptoms than the control group. Moreover, we found that HD patients with recurrent nightmares had a higher prevalence of indefinite complaints than the control group. In this study, the presence of dream anxiety in recurrent nightmare refers to the HD patients' experiences, and not to findings from objective clinical assessments. However, the results of the VDAS, scored as an objective measure, clearly reflected patient experiences such as the effects of sleep disorders, psychological states, and symptoms of autonomic hyperactivity during sleep. Since subjective symptoms such as autonomic hyperactivity may cause the emergence of cardiovascular disease in HD patients, attention should be paid to patients whose recurrent nightmare with anxiety is accompanied by increased heart rate. Increased heart rate is clearly correlated with myocardial ischemia [23] .
Many HD patients present with various somatic complaints due to psychological problems caused by restrictions imposed on their daily life by HD therapy. Not only sleep disorders and depressive symptoms, but also various other symptoms, such as indefinite complaints associated with HD therapy, can occur. The most frequently reported complaints caused by sleep disorders are restless legs syndrome and uremic pruritus [24, 25] . In addition, muscle cramps due to body fluid imbalances and IDH can also cause sleep problems [26] . In the present study, patients with recurrent nightmare (i.e., those in the nightmare sufferers group) had higher scores for the presence of restless legs syndrome, uremic pruritus, and IDH than those without nightmare (i.e., the control group). These results are in agreement with previous studies, and these complaints may influence sleep quality. Additionally, the presence of feelings of malaise was associated with recurrent nightmare. That is, the ORs for the presence of feelings of malaise were statistically significant. The involvement of indefinite complaints, such as the presence of feelings of malaise, in dream anxiety in recurrent nightmare requires further elucidation. Understanding the psychological state of nightmare can provide insight into its pathophysiology and help in the design of clinical management for HD patients.
Our study had some limitations. The associations were obtained using a cross-sectional design, which did not allow us to draw causal conclusions with confidence. Therefore, more prospective studies are needed to determine if dream anxiety in nightmare in HD patients is associated with patients' detailed character and background. Symptoms and conditions were evaluated using only questionnaires; therefore, we could not eliminate the possibility of a multifaceted psychological impact on the results. Using two or more different kinds of questionnaires for psychological testing could be required to more thoroughly assess nightmare and patient states. Relatively few patients were enrolled in this study; all observations should be confirmed in a larger sample. Our findings are not informative enough for a definitive diagnosis for sleep, because we did not perform other objective sleep measurements such as polysomnography to examine sleep apnea syndrome or periodic limb movement in our observations. Also, we did not take into the consideration the psychosocial dimensions, including economic status, family support, and some other emotional stresses related to sleep. In future research, we need to consider the patients' sleep-related symptoms and patient background factors. In this study, we did not use the VDAS but the subjective evaluation based on patient self-assessment to assess the presence of dream anxiety in nightmare, since we could not investigate the clear content of the nightmare with using VDAS. We should have used the objective indicators as the VDAS in theory. It is common to use multivariate analysis in situations in which there are two or more covariates or response variables. The several covariates used in multivariate analysis are not only directly influenced by response variables but are also affected by other covariates which often hinders analysis. The reason we chose univariate analysis rather than multivariate analysis was a desire to treat VAS questionnaire items as factors independent of one another and to remove the effects between covariates. However, in this study, it was necessary to use propensity score in order to effectively remove the effect of confounding factors.
CONCLUSION
In summary, we found that the presence of feelings of malaise was an independent risk factor for nightmare among patients undergoing HD. In particular, feelings of malaise have a role in the psychological state, and their treatment could help reduce the frequency of nightmares or sleep disorders in patients undergoing HD. Furthermore, our findings will be useful when considering adjustment of patients' HD dose. In the clinical assessment of patients' indefinite complaints, we could notify that inappropriate sleep of HD patients can cause psychological and physiological symptoms.
